Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Silo Pharma Announces Device And CMC Development Master Plan With Resyca BV For Nose-To-Brain Drug Delivery; Promising Safety And Therapeutic Benefit Observed; Plan Supports IND-Enabling Studies For Lead Candidate SPC-15, An Intranasal Treatment For PTSD

Author: Benzinga Newsdesk | July 18, 2024 08:25am

Posted In: SILO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist